Your browser doesn't support javascript.
loading
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
Bonnefoi, Hervé; MacGrogan, Gaetan; Poncet, Coralie; Iggo, Richard; Pommeret, Fanny; Grellety, Thomas; Larsimont, Denis; Bécette, Véronique; Kerdraon, Olivier; Bibeau, Frédéric; Ghnassia, Jean-Pierre; Picquenot, Jean-Michel; Thomas, Jeremy; Tille, Jean-Christophe; Slaets, Leen; Bodmer, Alexandre; Bergh, Jonas; Cameron, David.
Afiliação
  • Bonnefoi H; Department of Medical Oncology, Institut Bergonié Unicancer, University of Bordeaux, INSERM U1218, INSERM CIC1401, Bordeaux, France. h.bonnefoi@bordeaux.unicancer.fr.
  • MacGrogan G; Department of BioPathology, Institut Bergonié Unicancer, INSERM U1218, Bordeaux, France.
  • Poncet C; European Organisation for Research and Treatment of Cancer EORTC) Headquarters, Brussels, Belgium.
  • Iggo R; Institut Bergonié Unicancer, INSERM U1218, Bordeaux, France.
  • Pommeret F; Department of Medical Oncology, Institut Bergonié Unicancer, University of Bordeaux, INSERM U1218, INSERM CIC1401, Bordeaux, France.
  • Grellety T; Department of Medical Oncology, Institut Bergonié Unicancer, University of Bordeaux, INSERM U1218, INSERM CIC1401, Bordeaux, France.
  • Larsimont D; Department of Pathology, Institut Jules Bordet, Brussels, Belgium.
  • Bécette V; Department of Pathology, Institut Curie-Hôpital René Huguenin, Saint-Cloud, France.
  • Kerdraon O; Department of Pathology, Centre René Gauducheau, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Bibeau F; Department of Pathology, Institut de Cancérologie de Montpellier (ICM), Montpellier, France.
  • Ghnassia JP; Department of Pathology, Centre Paul Strauss, Strasbourg, France.
  • Picquenot JM; Department of Pathology, Centre Henri Becquerel, Rouen, France.
  • Thomas J; Department of Pathology, Edinburgh Cancer Centre, University of Edinburgh, Edinburgh, United Kingdom.
  • Tille JC; Department of Pathologie, Hôpitaux Universitaires de Genève (HUG), Geneva, Switzerland.
  • Slaets L; European Organisation for Research and Treatment of Cancer EORTC) Headquarters, Brussels, Belgium.
  • Bodmer A; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Bergh J; Department of Oncology, Hôpitaux Universitaires de Genève (HUG), Geneva, Switzerland.
  • Cameron D; Swedish Breast Cancer Group (SweBCG), Stockholm, Sweden.
Br J Cancer ; 120(9): 913-921, 2019 04.
Article em En | MEDLINE | ID: mdl-30899086
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França